{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:16:34Z","timestamp":1791476194873,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jpba.2022.115028","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:03:33Z","timestamp":1662552213000},"page":"115028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism"],"prefix":"10.1016","volume":"221","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115028_bib1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2022.115028_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2022.115028_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm9020458","article-title":"Inflammatory targets in diabetic nephropathy","volume":"9","author":"Donate-Correa","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpba.2022.115028_bib4","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/ijms21062218","article-title":"Glucose and blood pressure-dependent pathways-the progression of diabetic kidney disease","volume":"21","author":"Patel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2022.115028_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL study investigators, effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2022.115028_bib6","article-title":"The active compounds and therapeutic target of Tripterygium wilfordii Hook. f. in attenuating proteinuria in diabetic nephropathy: a review","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jpba.2022.115028_bib7","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.apsb.2020.12.020","article-title":"Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management","volume":"11","author":"Tang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpba.2022.115028_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/med.21762","article-title":"Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jpba.2022.115028_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9181037","article-title":"Tripterygium wilfordii Hook F treatment for stage IV diabetic nephropathy: protocol for a prospective, randomized controlled trial","volume":"2020","author":"Lengnan","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jpba.2022.115028_bib10","article-title":"Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis","volume":"99","author":"Jin","year":"2020","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.jpba.2022.115028_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12519-016-0032-z","article-title":"Tripterygium wilfordii Hook F is efficacious in the treatment of Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"12","author":"Mao","year":"2016","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.jpba.2022.115028_bib12","article-title":"Pharmacokinetics-based chronoefficacy of Semen Strychni and tripterygium glycoside tablet against rheumatoid arthritis","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2022.115028_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13102818.2014.989727","article-title":"Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease","volume":"29","author":"Ma","year":"2015","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.jpba.2022.115028_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12882-021-02487-8","article-title":"Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"22","author":"Guo","year":"2021","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.jpba.2022.115028_bib15","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2022.115028_bib16","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpba.2022.115028_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2017.142","article-title":"Modelling diabetic nephropathy in mice","volume":"14","author":"Azushima","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jpba.2022.115028_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jchromb.2015.03.011","article-title":"Simultaneous LC-MS\/MS determination of five tripterygium pyridine alkaloids in dog plasma and its application to their pharmacokinetic study after oral administration of tripterygium glycosides tablets","volume":"990","author":"Su","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2022.115028_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3892\/ijmm.2017.3068","article-title":"Multi-glycoside of Tripterygium wilfordii Hook. f. attenuates glomerulosclerosis in a rat model of diabetic nephropathy by exerting anti-microinflammatory effects without affecting hyperglycemia","volume":"40","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.jpba.2022.115028_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020999118","article-title":"Distinct roles of adipose triglyceride lipase and hormone-sensitive lipase in the catabolism of triacylglycerol estolides","volume":"118","author":"Brejchova","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jpba.2022.115028_bib21","first-page":"1331","article-title":"Considerations on establishing clinically relevant specifications of traditional Chinese medicine preparations with tripterygium glycoside tablets as an example","volume":"23","author":"Sun","year":"2021","journal-title":"Mod. Chin. Med."},{"key":"10.1016\/j.jpba.2022.115028_bib22","doi-asserted-by":"crossref","first-page":"eaax6208","DOI":"10.1126\/sciadv.aax6208","article-title":"Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jpba.2022.115028_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3892\/mmr.2021.12231","article-title":"Tripterygium glycoside suppresses epithelial-to-mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR\/Twist1 pathway","volume":"24","author":"Tao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jpba.2022.115028_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00125-020-05201-9","article-title":"FinnDiane study group, sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes","volume":"63","author":"Barlovic","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpba.2022.115028_bib25","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00216-015-8481-0","article-title":"Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy","volume":"407","author":"Liu","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2022.115028_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.kint.2018.04.025","article-title":"Sodium\u2013glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice","volume":"94","author":"Tanaka","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.jpba.2022.115028_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1681\/ASN.2015030302","article-title":"Metabolomics reveals a key role for fumarate in mediating the effects of NADPH oxidase 4 in diabetic kidney disease","volume":"27","author":"You","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2022.115028_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/nu13051389","article-title":"Dietary strategies for management of metabolic syndrome: role of gut microbiota metabolites","volume":"13","author":"Croci","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jpba.2022.115028_bib29","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/jcmm.14187","article-title":"Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients","volume":"23","author":"Ma","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.jpba.2022.115028_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2022.115028_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jpba.2022.115028_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","article-title":"Lipotoxicity as a trigger factor of renal disease","volume":"29","author":"Izquierdo-Lahuerta","year":"2016","journal-title":"J. Nephrol."},{"key":"10.1016\/j.jpba.2022.115028_bib33","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpba.2022.115028_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/febs.14038","article-title":"Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage","volume":"284","author":"Chen","year":"2017","journal-title":"FEBS J."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:22:16Z","timestamp":1760001736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"alternative-id":["S0731708522004496"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115028","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115028"}}